PAM
LAB icon

Paradigm Asset Management’s Standard BioTools LAB Stock Holding History

Paradigm Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-60,300
Closed -$489K – 820
2015
Q3 		$489K Sell
60,300
-3,900
-6% -$61.4K 0.06% 285
2015
Q2 		$1.55M Sell
64,200
-1,200
-2% -$37.9K 0.17% 159
2015
Q1 		$2.75M Sell
65,400
-14,500
-18% -$573K 0.31% 106
2014
Q4 		$2.7M Buy
+79,900
New +$2.26M 0.35% 99

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Paradigm Asset Management's LAB Position: Q4 2015 in Review

Paradigm Asset Management sold out of Standard BioTools (LAB) in Q4 2015, closing a stake of 60,300 shares — an estimated $489K sold.

Paradigm Asset Management first reported a position in LAB in Q4 2014 and held it in 4 quarters. The position peaked at $2.75M in Q1 2015. 106 funds tracked by Wall St. Rank hold LAB as of Q4 2015.

  • Paradigm Asset Management reported no remaining Standard BioTools position as of Q4 2015 after selling out during the quarter.
  • Paradigm Asset Management sold 60,300 Standard BioTools shares in Q4 2015, an estimated $489K.
  • Paradigm Asset Management first reported a position in Standard BioTools in Q4 2014 and held it in 4 quarters.
  • Paradigm Asset Management's Standard BioTools position peaked at $2.75M in Q1 2015.
  • 106 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2015.

Based on Paradigm Asset Management's 13F filing for Q4 2015, filed 5 Feb 2016.